Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 131

1.

Identification of survivin as a promising target for the immunotherapy of adult B-cell acute lymphoblastic leukemia.

Boullosa LF, Savaliya P, Bonney S, Orchard L, Wickenden H, Lee C, Smits E, Banham AH, Mills KI, Orchard K, Guinn BA.

Oncotarget. 2017 Dec 17;9(3):3853-3866. doi: 10.18632/oncotarget.23380. eCollection 2018 Jan 9.

2.

Sp17 Protein Expression and Major Histocompatibility Class I and II Epitope Presentation in Diffuse Large B Cell Lymphoma Patients.

Ait-Tahar K, Anderson AP, Barnardo M, Collins GP, Hatton CSR, Banham AH, Pulford K.

Adv Hematol. 2017;2017:6527306. doi: 10.1155/2017/6527306. Epub 2017 Oct 24.

3.

DNMT1 is predictive of survival and associated with Ki-67 expression in R-CHOP-treated diffuse large B-cell lymphomas.

Loo SK, Ch'ng ES, Lawrie CH, Muruzabal MA, Gaafar A, Pomposo MP, Husin A, Md Salleh MS, Banham AH, Pedersen LM, Møller MB, Green TM, Wong KK.

Pathology. 2017 Dec;49(7):731-739. doi: 10.1016/j.pathol.2017.08.009. Epub 2017 Oct 23.

PMID:
29074044
4.

Therapeutic Antibodies against Intracellular Tumor Antigens.

Trenevska I, Li D, Banham AH.

Front Immunol. 2017 Aug 18;8:1001. doi: 10.3389/fimmu.2017.01001. eCollection 2017. Review.

5.

Engineering chimeric human and mouse major histocompatibility complex (MHC) class I tetramers for the production of T-cell receptor (TCR) mimic antibodies.

Li D, Bentley C, Yates J, Salimi M, Greig J, Wiblin S, Hassanali T, Banham AH.

PLoS One. 2017 Apr 27;12(4):e0176642. doi: 10.1371/journal.pone.0176642. eCollection 2017.

6.

Development of a T-cell Receptor Mimic Antibody against Wild-Type p53 for Cancer Immunotherapy.

Li D, Bentley C, Anderson A, Wiblin S, Cleary KLS, Koustoulidou S, Hassanali T, Yates J, Greig J, Nordkamp MO, Trenevska I, Ternette N, Kessler BM, Cornelissen B, Cragg MS, Banham AH.

Cancer Res. 2017 May 15;77(10):2699-2711. doi: 10.1158/0008-5472.CAN-16-3247. Epub 2017 Mar 31.

7.

TRPM4 expression is associated with activated B cell subtype and poor survival in diffuse large B cell lymphoma.

Loo SK, Ch'ng ES, Md Salleh MS, Banham AH, Pedersen LM, Møller MB, Green TM, Wong KK.

Histopathology. 2017 Jul;71(1):98-111. doi: 10.1111/his.13204. Epub 2017 Apr 27.

PMID:
28248435
8.

Vitamin D Receptor Expression in Plasmablastic Lymphoma and Myeloma Cells Confers Susceptibility to Vitamin D.

Gascoyne DM, Lyne L, Spearman H, Buffa FM, Soilleux EJ, Banham AH.

Endocrinology. 2017 Mar 1;158(3):503-515. doi: 10.1210/en.2016-1802.

9.

The significance of FOXP1 in diffuse large B-cell lymphoma.

Gascoyne DM, Banham AH.

Leuk Lymphoma. 2017 May;58(5):1037-1051. doi: 10.1080/10428194.2016.1228932. Epub 2016 Sep 27. Review.

PMID:
27678023
10.

FOXP2-positive diffuse large B-cell lymphomas exhibit a poor response to R-CHOP therapy and distinct biological signatures.

Wong KK, Gascoyne DM, Soilleux EJ, Lyne L, Spearman H, Roncador G, Pedersen LM, Møller MB, Green TM, Banham AH.

Oncotarget. 2016 Aug 16;7(33):52940-52956. doi: 10.18632/oncotarget.9507.

11.

N-terminally truncated FOXP1 protein expression and alternate internal FOXP1 promoter usage in normal and malignant B cells.

Brown PJ, Gascoyne DM, Lyne L, Spearman H, Felce SL, McFadden N, Chakravarty P, Barrans S, Lynham S, Calado DP, Ward M, Banham AH.

Haematologica. 2016 Jul;101(7):861-71. doi: 10.3324/haematol.2016.142141. Epub 2016 Apr 7.

12.

Notch signaling: its roles and therapeutic potential in hematological malignancies.

Gu Y, Masiero M, Banham AH.

Oncotarget. 2016 May 17;7(20):29804-23. doi: 10.18632/oncotarget.7772. Review.

13.

FOXP1 suppresses immune response signatures and MHC class II expression in activated B-cell-like diffuse large B-cell lymphomas.

Brown PJ, Wong KK, Felce SL, Lyne L, Spearman H, Soilleux EJ, Pedersen LM, Møller MB, Green TM, Gascoyne DM, Banham AH.

Leukemia. 2016 Mar;30(3):605-16. doi: 10.1038/leu.2015.299. Epub 2015 Oct 26.

14.

Application of the pMHC Array to Characterise Tumour Antigen Specific T Cell Populations in Leukaemia Patients at Disease Diagnosis.

Brooks SE, Bonney SA, Lee C, Publicover A, Khan G, Smits EL, Sigurdardottir D, Arno M, Li D, Mills KI, Pulford K, Banham AH, van Tendeloo V, Mufti GJ, Rammensee HG, Elliott TJ, Orchard KH, Guinn BA.

PLoS One. 2015 Oct 22;10(10):e0140483. doi: 10.1371/journal.pone.0140483. eCollection 2015.

15.

The European antibody network's practical guide to finding and validating suitable antibodies for research.

Roncador G, Engel P, Maestre L, Anderson AP, Cordell JL, Cragg MS, Šerbec VČ, Jones M, Lisnic VJ, Kremer L, Li D, Koch-Nolte F, Pascual N, Rodríguez-Barbosa JI, Torensma R, Turley H, Pulford K, Banham AH.

MAbs. 2016;8(1):27-36. doi: 10.1080/19420862.2015.1100787. Epub 2015 Sep 29.

16.

Low HIP1R mRNA and protein expression are associated with worse survival in diffuse large B-cell lymphoma patients treated with R-CHOP.

Wong KK, Ch'ng ES, Loo SK, Husin A, Muruzabal MA, Møller MB, Pedersen LM, Pomposo MP, Gaafar A, Banham AH, Green TM, Lawrie CH.

Exp Mol Pathol. 2015 Dec;99(3):537-45. doi: 10.1016/j.yexmp.2015.08.019. Epub 2015 Sep 2.

PMID:
26341140
17.

The Forkhead Transcription Factor FOXP2 Is Required for Regulation of p21WAF1/CIP1 in 143B Osteosarcoma Cell Growth Arrest.

Gascoyne DM, Spearman H, Lyne L, Puliyadi R, Perez-Alcantara M, Coulton L, Fisher SE, Croucher PI, Banham AH.

PLoS One. 2015 Jun 2;10(6):e0128513. doi: 10.1371/journal.pone.0128513. eCollection 2015.

18.

Pim-2 Kinase Influences Regulatory T Cell Function and Stability by Mediating Foxp3 Protein N-terminal Phosphorylation.

Deng G, Nagai Y, Xiao Y, Li Z, Dai S, Ohtani T, Banham A, Li B, Wu SL, Hancock W, Samanta A, Zhang H, Greene MI.

J Biol Chem. 2015 Aug 14;290(33):20211-20. doi: 10.1074/jbc.M115.638221. Epub 2015 May 18.

19.

Cancer/Testis Antigen PASD1 Silences the Circadian Clock.

Michael AK, Harvey SL, Sammons PJ, Anderson AP, Kopalle HM, Banham AH, Partch CL.

Mol Cell. 2015 Jun 4;58(5):743-54. doi: 10.1016/j.molcel.2015.03.031. Epub 2015 Apr 30.

20.

A novel zinc finger gene, ZNF465, is inappropriately expressed in acute myeloid leukaemia cells.

Collin JF, Wells JW, Czepulkowski B, Lyne L, Duriez PJ, Banham AH, Mufti GJ, Guinn BA.

Genes Chromosomes Cancer. 2015 May;54(5):288-302. doi: 10.1002/gcc.22242. Epub 2015 Feb 23.

PMID:
25706801
21.

A review of ELTD1, a pro-angiogenic adhesion GPCR.

Favara DM, Banham AH, Harris AL.

Biochem Soc Trans. 2014 Dec;42(6):1658-64. doi: 10.1042/BST20140216. Review.

PMID:
25399586
22.

The notch ligand JAGGED1 as a target for anti-tumor therapy.

Li D, Masiero M, Banham AH, Harris AL.

Front Oncol. 2014 Sep 25;4:254. doi: 10.3389/fonc.2014.00254. eCollection 2014. Review.

23.

Increased Expression of Phosphorylated FADD in Anaplastic Large Cell and Other T-Cell Lymphomas.

Patel S, Murphy D, Haralambieva E, Abdulla ZA, Wong KK, Chen H, Gould E, Roncador G, Hatton C, Anderson AP, Banham AH, Pulford K.

Biomark Insights. 2014 Sep 3;9:77-84. doi: 10.4137/BMI.S16553. eCollection 2014.

24.

Elevated receptor for activated C kinase 1 expression is involved in intracellular Ca2+ influx and potentially associated with compromised regulatory T cell function in patients with asthma.

Negoro T, Shimizu S, Narushima M, Banham AH, Wakabayashi H, Takayanagi R, Hagiwara T, Roncador G, Osabe T, Yanai T, Kin M, Ikeda K, Endo A, Akiyama H, Nakano Y.

Clin Exp Allergy. 2014 Sep;44(9):1154-69. doi: 10.1111/cea.12375.

PMID:
25048599
25.

Quantification of hepatic FOXP3+ T-lymphocytes in HIV/hepatitis C coinfection.

Williams SK, Donaldson E, Van der Kleij T, Dixon L, Fisher M, Tibble J, Gilleece Y, Klenerman P, Banham AH, Howard M, Webster DP.

J Viral Hepat. 2014 Apr;21(4):251-9. doi: 10.1111/jvh.12141. Epub 2013 Aug 15.

26.

Reciprocal expression of the endocytic protein HIP1R and its repressor FOXP1 predicts outcome in R-CHOP-treated diffuse large B-cell lymphoma patients.

Wong KK, Gascoyne DM, Brown PJ, Soilleux EJ, Snell C, Chen H, Lyne L, Lawrie CH, Gascoyne RD, Pedersen LM, Møller MB, Pulford K, Murphy D, Green TM, Banham AH.

Leukemia. 2014 Feb;28(2):362-72. doi: 10.1038/leu.2013.224. Epub 2013 Jul 25. Erratum in: Leukemia. 2014 Feb;28(2):470.

PMID:
23884370
27.

A core human primary tumor angiogenesis signature identifies the endothelial orphan receptor ELTD1 as a key regulator of angiogenesis.

Masiero M, Simões FC, Han HD, Snell C, Peterkin T, Bridges E, Mangala LS, Wu SY, Pradeep S, Li D, Han C, Dalton H, Lopez-Berestein G, Tuynman JB, Mortensen N, Li JL, Patient R, Sood AK, Banham AH, Harris AL, Buffa FM.

Cancer Cell. 2013 Aug 12;24(2):229-41. doi: 10.1016/j.ccr.2013.06.004. Epub 2013 Jul 18.

28.

Molecular basis for Jagged-1/Serrate ligand recognition by the Notch receptor.

Whiteman P, de Madrid BH, Taylor P, Li D, Heslop R, Viticheep N, Tan JZ, Shimizu H, Callaghan J, Masiero M, Li JL, Banham AH, Harris AL, Lea SM, Redfield C, Baron M, Handford PA.

J Biol Chem. 2013 Mar 8;288(10):7305-12. doi: 10.1074/jbc.M112.428854. Epub 2013 Jan 21.

29.

RNASET2--an autoantigen in anaplastic large cell lymphoma identified by protein array analysis.

Patel S, Chen H, Monti L, Gould E, Haralambieva E, Schmid J, Toomey D, Woessmann W, Roncador G, Hatton CS, Liggins AP, Taramelli R, Banham AH, Acquati F, Murphy D, Pulford K.

J Proteomics. 2012 Sep 18;75(17):5279-92. doi: 10.1016/j.jprot.2012.06.009. Epub 2012 Jun 23.

PMID:
22732457
30.

The transcription factor encyclopedia.

Yusuf D, Butland SL, Swanson MI, Bolotin E, Ticoll A, Cheung WA, Zhang XY, Dickman CT, Fulton DL, Lim JS, Schnabl JM, Ramos OH, Vasseur-Cognet M, de Leeuw CN, Simpson EM, Ryffel GU, Lam EW, Kist R, Wilson MS, Marco-Ferreres R, Brosens JJ, Beccari LL, Bovolenta P, Benayoun BA, Monteiro LJ, Schwenen HD, Grontved L, Wederell E, Mandrup S, Veitia RA, Chakravarthy H, Hoodless PA, Mancarelli MM, Torbett BE, Banham AH, Reddy SP, Cullum RL, Liedtke M, Tschan MP, Vaz M, Rizzino A, Zannini M, Frietze S, Farnham PJ, Eijkelenboom A, Brown PJ, Laperrière D, Leprince D, de Cristofaro T, Prince KL, Putker M, del Peso L, Camenisch G, Wenger RH, Mikula M, Rozendaal M, Mader S, Ostrowski J, Rhodes SJ, Van Rechem C, Boulay G, Olechnowicz SW, Breslin MB, Lan MS, Nanan KK, Wegner M, Hou J, Mullen RD, Colvin SC, Noy PJ, Webb CF, Witek ME, Ferrell S, Daniel JM, Park J, Waldman SA, Peet DJ, Taggart M, Jayaraman PS, Karrich JJ, Blom B, Vesuna F, O'Geen H, Sun Y, Gronostajski RM, Woodcroft MW, Hough MR, Chen E, Europe-Finner GN, Karolczak-Bayatti M, Bailey J, Hankinson O, Raman V, LeBrun DP, Biswal S, Harvey CJ, DeBruyne JP, Hogenesch JB, Hevner RF, Héligon C, Luo XM, Blank MC, Millen KJ, Sharlin DS, Forrest D, Dahlman-Wright K, Zhao C, Mishima Y, Sinha S, Chakrabarti R, Portales-Casamar E, Sladek FM, Bradley PH, Wasserman WW.

Genome Biol. 2012;13(3):R24. doi: 10.1186/gb-2012-13-3-r24.

31.

Identification and characterization of peripheral T-cell lymphoma-associated SEREX antigens.

Cooper CD, Lawrie CH, Liggins AP, Collins GP, Hatton CS, Pulford K, Banham AH.

PLoS One. 2011;6(8):e23916. doi: 10.1371/journal.pone.0023916. Epub 2011 Aug 22.

32.

Impaired Ca²⁺ regulation of CD4⁺CD25⁺ regulatory T cells from pediatric asthma.

Yamamoto Y, Negoro T, Hoshi A, Wakagi A, Shimizu S, Banham AH, Ishii M, Akiyama H, Kiuchi Y, Sunaga S, Tobe T, Roncador G, Itabashi K, Nakano Y.

Int Arch Allergy Immunol. 2011;156(2):148-58. doi: 10.1159/000322845. Epub 2011 May 17.

PMID:
21576985
33.

Recruitment of regulatory T cells is correlated with hypoxia-induced CXCR4 expression, and is associated with poor prognosis in basal-like breast cancers.

Yan M, Jene N, Byrne D, Millar EK, O'Toole SA, McNeil CM, Bates GJ, Harris AL, Banham AH, Sutherland RL, Fox SB.

Breast Cancer Res. 2011 Apr 26;13(2):R47. doi: 10.1186/bcr2869.

34.

DNA vaccines to target the cancer testis antigen PASD1 in human multiple myeloma.

Joseph-Pietras D, Gao Y, Zojer N, Ait-Tahar K, Banham AH, Pulford K, Rice J, Savelyeva N, Sahota SS.

Leukemia. 2010 Nov;24(11):1951-9. doi: 10.1038/leu.2010.196. Epub 2010 Sep 23.

PMID:
20861911
35.

CD4-positive T-helper cell responses to the PASD1 protein in patients with diffuse large B-cell lymphoma.

Ait-Tahar K, Liggins AP, Collins GP, Campbell A, Barnardo M, Cabes M, Lawrie CH, Moir D, Hatton C, Banham AH, Pulford K.

Haematologica. 2011 Jan;96(1):78-86. doi: 10.3324/haematol.2010.028241. Epub 2010 Sep 17.

36.

A panel of cancer-testis genes exhibiting broad-spectrum expression in haematological malignancies.

Liggins AP, Lim SH, Soilleux EJ, Pulford K, Banham AH.

Cancer Immun. 2010 Aug 23;10:8.

37.

Comparison of Choi and Hans' algorithms by immunohistochemistry and quantitative reverse transcriptase-PCR - letter.

Ballabio E, Chi J, Roncador G, Banham AH, Hatton CS, Lawrie CH.

Clin Cancer Res. 2010 Jul 15;16(14):3805-6. doi: 10.1158/1078-0432.CCR-09-3216. Epub 2010 Jul 13. No abstract available.

38.

Targeted phototherapy of plaque-type psoriasis using ultraviolet B-light-emitting diodes.

Kemény L, Csoma Z, Bagdi E, Banham AH, Krenács L, Koreck A.

Br J Dermatol. 2010 Jul;163(1):167-73. doi: 10.1111/j.1365-2133.2010.09763.x. Epub 2010 Mar 10.

PMID:
20302573
39.

Aberrant expression of the neuronal transcription factor FOXP2 in neoplastic plasma cells.

Campbell AJ, Lyne L, Brown PJ, Launchbury RJ, Bignone P, Chi J, Roncador G, Lawrie CH, Gatter KC, Kusec R, Banham AH.

Br J Haematol. 2010 Apr;149(2):221-30. doi: 10.1111/j.1365-2141.2009.08070.x. Epub 2010 Jan 20.

PMID:
20096010
40.

Ribosome-associated nucleophosmin 1: increased expression and shuttling activity distinguishes prognostic subtypes in chronic lymphocytic leukaemia.

Rees-Unwin KS, Faragher R, Unwin RD, Adams J, Brown PJ, Buckle AM, Pettitt A, Hutchinson CV, Johnson SM, Pulford K, Banham AH, Whetton AD, Lucas G, Mason DY, Burthem J.

Br J Haematol. 2010 Feb;148(4):534-43. doi: 10.1111/j.1365-2141.2009.07979.x. Epub 2009 Nov 23.

PMID:
19961478
41.

Immuno-fluorescence in situ hybridization index predicts survival in patients with diffuse large B-cell lymphoma treated with R-CHOP: a GELA study.

Copie-Bergman C, Gaulard P, Leroy K, Briere J, Baia M, Jais JP, Salles GA, Berger F, Haioun C, Tilly H, Emile JF, Banham AH, Mounier N, Gisselbrecht C, Feugier P, Coiffier B, Molina TJ.

J Clin Oncol. 2009 Nov 20;27(33):5573-9. doi: 10.1200/JCO.2009.22.7058. Epub 2009 Sep 28.

PMID:
19786664
42.

Immunophenotypic analysis of AIDS-related diffuse large B-cell lymphoma and clinical implications in patients from AIDS Malignancies Consortium clinical trials 010 and 034.

Chadburn A, Chiu A, Lee JY, Chen X, Hyjek E, Banham AH, Noy A, Kaplan LD, Sparano JA, Bhatia K, Cesarman E.

J Clin Oncol. 2009 Oct 20;27(30):5039-48. doi: 10.1200/JCO.2008.20.5450. Epub 2009 Sep 14.

43.

A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy.

Choi WW, Weisenburger DD, Greiner TC, Piris MA, Banham AH, Delabie J, Braziel RM, Geng H, Iqbal J, Lenz G, Vose JM, Hans CP, Fu K, Smith LM, Li M, Liu Z, Gascoyne RD, Rosenwald A, Ott G, Rimsza LM, Campo E, Jaffe ES, Jaye DL, Staudt LM, Chan WC.

Clin Cancer Res. 2009 Sep 1;15(17):5494-502. doi: 10.1158/1078-0432.CCR-09-0113. Epub 2009 Aug 25.

44.

Expression of the forkhead box transcription factor FOXP1 is associated with oestrogen receptor alpha, oestrogen receptor beta and improved survival in familial breast cancers.

Rayoo M, Yan M, Takano EA, Bates GJ, Brown PJ, Banham AH, Fox SB.

J Clin Pathol. 2009 Oct;62(10):896-902. doi: 10.1136/jcp.2009.065169. Epub 2009 Jul 20.

PMID:
19622517
45.

Cytolytic T-cell response to the PASD1 cancer testis antigen in patients with diffuse large B-cell lymphoma.

Ait-Tahar K, Liggins AP, Collins GP, Campbell A, Barnardo M, Lawrie C, Moir D, Hatton C, Banham AH, Pulford K.

Br J Haematol. 2009 Aug;146(4):396-407. doi: 10.1111/j.1365-2141.2009.07761.x. Epub 2009 Jun 22.

PMID:
19552722
46.

Therapeutic targeting of FOXP3-positive regulatory T cells using a FOXP3 peptide vaccine WO2008081581.

Banham AH, Pulford K.

Expert Opin Ther Pat. 2009 Jul;19(7):1023-8. doi: 10.1517/13543770902785183.

PMID:
19456276
47.

Prognostic impact of activated B-cell focused classification in diffuse large B-cell lymphoma patients treated with R-CHOP.

Nyman H, Jerkeman M, Karjalainen-Lindsberg ML, Banham AH, Leppä S.

Mod Pathol. 2009 Aug;22(8):1094-101. doi: 10.1038/modpathol.2009.73. Epub 2009 May 15.

48.

Regulatory T cells in atopic dermatitis: epidermal dendritic cell clusters may contribute to their local expansion.

Szegedi A, Baráth S, Nagy G, Szodoray P, Gál M, Sipka S, Bagdi E, Banham AH, Krenács L.

Br J Dermatol. 2009 May;160(5):984-93. doi: 10.1111/j.1365-2133.2009.09035.x. Epub 2009 Feb 16.

PMID:
19222459
49.

Immunomodulation of FOXP3+ regulatory T cells by the aromatase inhibitor letrozole in breast cancer patients.

Generali D, Bates G, Berruti A, Brizzi MP, Campo L, Bonardi S, Bersiga A, Allevi G, Milani M, Aguggini S, Dogliotti L, Banham AH, Harris AL, Bottini A, Fox SB.

Clin Cancer Res. 2009 Feb 1;15(3):1046-51. doi: 10.1158/1078-0432.CCR-08-1507.

50.

Bcl-2 but not FOXP1, is an adverse risk factor in immunochemotherapy-treated non-germinal center diffuse large B-cell lymphomas.

Nyman H, Jerkeman M, Karjalainen-Lindsberg ML, Banham AH, Enblad G, Leppä S.

Eur J Haematol. 2009 May;82(5):364-72. doi: 10.1111/j.1600-0609.2009.01222.x. Epub 2009 Jan 9.

PMID:
19141121

Supplemental Content

Loading ...
Support Center